Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr;133(1):43-7.
doi: 10.1016/j.ygyno.2014.01.017. Epub 2014 Jan 17.

Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables

Amy S Joehlin-Price  1 , Carmen M Perrino  2 , Julie Stephens  3 , Floor J Backes  4 , Paul J Goodfellow  4 , David E Cohn  4 , Adrian A Suarez  5
Affiliations

Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables

Amy S Joehlin-Price et al. Gynecol Oncol. 2014 Apr.

Abstract

Objective: Links between obesity, with its attendant estrogen abnormalities, and the endometrial carcinoma (EC) DNA Mismatch Repair Protein (MMR) system have recently been proposed. We investigated relationships between body mass index (BMI) and clinicopathological correlates including MMR expression in a large single institution EC cohort.

Methods: Clinical and pathological databases from 2007 to 2012 were used to identify consecutive hysterectomy specimens with EC. Univariate and multivariate analyses were used to explore relationships between BMI, age, stage, tumor type and immunohistochemical results for MLH1, PMS2, MSH2 and MSH6.

Results: 1049 EC were identified. Overall, BMI was higher amongst women with normal MMR (p=0.002). However, when stratified by age and specific MMR, statistically significant differences localized exclusively to women <50years old with loss of MSH2 and/or MSH6 (p=0.003 and p=0.005 respectively). Higher BMI correlated with endometrioid FIGO 1 and 2 tumors (p<0.001) and with stage 1a (p<0.001). Conversely, MMR abnormalities did not show significant associations with stage (p=0.302) or histologic grade (p=0.097).

Conclusions: BMI showed statistically significant associations with MMR expression, tumor grade and stage amongst 1049 consecutive EC. Obesity correlates with lower grade and stage EC. A link between BMI and maintenance of the MMR system is not supported by our data because the only statistically significant association occurred in women <50years old with MSH2 and/or MSH6 abnormalities where Lynch syndrome related cases are expected to cluster.

Keywords: BMI; Body mass index; DNA mismatch repair protein; Endometrial cancer; MMR.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors report no conflicts of interest or disclosures associated with this work.

Figures

Figure 1
Figure 1
BMI data stratified by MMR protein absence (any protein absent, and individual MLH1, PMS2, MSH2, or MSH6 absent), compared to a control group of women with all MMR proteins present. Comparison demonstrates that women with EC MMR intact have a higher BMI than those with any abnormal MMR protein (p=0.002). This largely holds true when stratified by the individual abnormal protein lost (remaining comparisons). Boxes: 25–75th percentile; whiskers: range; central line: mean; central dot: median.
Figure 2
Figure 2
Women <50 years of age who lack MSH2 and/or MSH6 in their EC specimens have markedly lower BMIs than their <50 year counterparts with all proteins intact (p=0.003 and p=0.005, respectively). Boxes: 25–75th percentile; whiskers: range; central line: mean; central dot: median.
See this image and copyright information in PMC

References

    1. Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, Lukanova A, et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC) Endocr Relat Cancer. 2008;15(2):485–497. - PMC - PubMed
    1. Bjorge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J, et al. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol. 2010;171(8):892–902. - PubMed
    1. Reeves KW, Carter GC, Rodabough RJ, Lane D, McNeeley SG, Stefanick ML, et al. Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative. Gynecol Oncol. 2011;121:376–382. - PMC - PubMed
    1. Polednak AP. Estimating the number of US incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-relatd cancers. Cancer Detect Prev. 2008;32(3):190–199. - PubMed
    1. Dossus L, Rinaldi H, Becker S, Lukanova A, Tjonneland A, Olsen A. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer. 2010;17(4):1007–1019. - PMC - PubMed

MeSH terms